COMMUNIQUÉS West-GlobeNewswire

Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
26/02/2018
PLAINSBORO, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ) today announced the appointment of Sravan Emany as vice president, treasurer and investor relations. Mr. [...]
Transactions under Novozymes’ stock buyback program
26/02/2018
Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/9f43fd0d-d7e8-4b8e-9772-a47ac79d48d0
Quest Diagnostics and Rutgers University Announce Sports Science Research Collaboration to Advance Athletic Performance
26/02/2018
Secaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers University–New Brunswick have [...]
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
26/02/2018
FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients DUBLIN - February 26, 2018 - Designed specifically for small vessels, [...]
Nova Leap Health Corp. Completes Purchase of Massachusetts Home Care Business, Reaches 280,000 Annualized Recurring Service Hours and Provides Update on Integration of Previous Acquisitions
26/02/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or “the Company”), a [...]
Adverum Biotechnologies to Present at Upcoming Investor Conferences
26/02/2018
MENLO PARK, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced [...]
REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold
26/02/2018
SAN DIEGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces CE Mark of the 2.5 millimeter [...]
Proximity Systems Announces New UV-Clean Self-Disinfecting Technology
26/02/2018
TOMBALL, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of innovative technology furniture solutions to healthcare , today announced its own Proximity UV-Clean self-disinfecting [...]
Adverum Biotechnologies Announces Completion of Dosing of First Cohort of Patients in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 Gene Therapy for A1AT Deficiency
26/02/2018
-- Data Monitoring Committee Recommends Proceeding to the Second Cohort -- -- Company Expects to Report Preliminary Data in the Second Half of 2018 -- MENLO PARK, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Adverum [...]
Novo Nordisk A/S: Election of employee representatives to the Board of Directors of Novo Nordisk A/
26/02/2018
Bagsværd, 26 February 2018 - The employees of Novo Nordisk A/S have conducted the election of employee representatives to the Board of Directors of Novo Nordisk A/S. The following members were elected for the next four [...]
Teladoc Earns Surescripts Certification for Medication History Services
26/02/2018
PURCHASE, NY, Feb. 26, 2018 (GLOBE NEWSWIRE) -- HIMSS Booth #3860 - Teladoc , Inc. (NYSE: TDOC ) the world’s largest and most trusted provider of virtual care delivery services, announced today that it has been [...]
Auris Medical to Host Key Opinion Leader Call Focused on Keyzilen® Tinnitus Program on March 5, 2018
26/02/2018
Zug, Switzerland, February 26, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced [...]
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Massachusetts Medical School to Advance AAV Gene Therapies
26/02/2018
SRA with lab of Guangping Gao, Ph.D., to explore construct optimization in AAV gene therapies for complement-mediated diseases Dr. Gao to serve as first member of Aevitas’ recently launched scientific advisory board NEW [...]
Hemispherx To Supply Ampligen for Pancreatic Cancer Patients in Canada Under Special Access Program
26/02/2018
ORLANDO, Fla., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) said it is expanding its partnership with myTomorrows to supply Ampligen® for pancreatic cancer patients in Canada under a [...]
Marrone Bio Innovations and Groundwork BioAg Bio-stacked Microbial Seed Treatments Result in Increased Corn and Soybean Yields for the Second Field Trial Season
26/02/2018
DAVIS, Calif. and MOSHAV MAZOR, Israel, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, [...]
Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests
26/02/2018
PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
26/02/2018
SOUTH ORANGE, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]
Avid Bioservices Announces Resignation of Chief Financial Officer
26/02/2018
TUSTIN, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]
Novo Nordisk A/S - Share repurchase programme
26/02/2018
Bagsværd, Denmark, 26 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Pages